476 related articles for article (PubMed ID: 12767952)
1. A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease.
Allison JE; Hurley LB; Hiatt RA; Levin TR; Ackerson LM; Lieu TA
Arch Intern Med; 2003 May; 163(10):1165-71. PubMed ID: 12767952
[TBL] [Abstract][Full Text] [Related]
2. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
Kearney DJ; Liu CF; Crump C; Brousal A
Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
[TBL] [Abstract][Full Text] [Related]
3. A cost analysis of a Helicobacter pylori eradication strategy in a large health maintenance organization.
Levin TR; Schmittdiel JA; Henning JM; Kunz K; Henke CJ; Colby CJ; Selby JV
Am J Gastroenterol; 1998 May; 93(5):743-7. PubMed ID: 9625120
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori test-and-treat intervention compared to usual care in primary care patients with suspected peptic ulcer disease in the United States.
Ladabaum U; Fendrick AM; Glidden D; Scheiman JM
Am J Gastroenterol; 2002 Dec; 97(12):3007-14. PubMed ID: 12492183
[TBL] [Abstract][Full Text] [Related]
5. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
[TBL] [Abstract][Full Text] [Related]
6. Eradicating Helicobacter pylori in peptic ulcer disease reduces medical costs in the community.
Sone Y; Kumada T; Toyoda H; Yokoyama M; Kato M; Asaka M
Helicobacter; 2008 Oct; 13(5):346-51. PubMed ID: 19250509
[TBL] [Abstract][Full Text] [Related]
7. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
[TBL] [Abstract][Full Text] [Related]
8. [The attitude of primary health care physicians in the metropolitan area of Barcelona about the diagnosis and treatment of Helicobacter pylori infection in gastroduodenal diseases].
Martínez-Sánchez G; Saperas E; Benavent J; Mearin F; Piñol JL; Barenys M; Mascort JJ; Forné M; Bordas JM; Azagra R; Piqué JM
Gastroenterol Hepatol; 1998 Dec; 21(10):473-8. PubMed ID: 9927791
[TBL] [Abstract][Full Text] [Related]
9. Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects.
Fendrick AM; McCort JT; Chernew ME; Hirth RA; Patel C; Bloom BS
Am J Gastroenterol; 1997 Nov; 92(11):2017-24. PubMed ID: 9362183
[TBL] [Abstract][Full Text] [Related]
10. Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial.
Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Kodama M; Fujioka T
J Gastroenterol Hepatol; 2006 Jun; 21(6):1048-53. PubMed ID: 16724993
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy.
Cherian PT; Cherian S; Singh P
Gastrointest Endosc; 2007 Sep; 66(3):491-7. PubMed ID: 17640640
[TBL] [Abstract][Full Text] [Related]
12. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
[TBL] [Abstract][Full Text] [Related]
13. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of an acid-peptic disease management program in a managed care environment.
Ofman JJ; Segal R; Russell WL; Cook DJ; Sandhu M; Maue SK; Lowenstein EH; Pourfarzib R; Blanchette E; Ellrodt G; Weingarten SR
Am J Manag Care; 2003 Jun; 9(6):425-33. PubMed ID: 12816172
[TBL] [Abstract][Full Text] [Related]
15. In-practice evaluation of whole-blood Helicobacter pylori test: its usefulness in detecting peptic ulcer disease.
Quartero AO; Numans ME; de Melker RA; de Wit NJ
Br J Gen Pract; 2000 Jan; 50(450):13-6. PubMed ID: 10695060
[TBL] [Abstract][Full Text] [Related]
16. Chronic acid-related disorders are common and underinvestigated.
Majumdar SR; Soumerai SB; Farraye FA; Lee M; Kemp JA; Henning JM; Schrammel P; LeCates RF; Ross-Degnan D
Am J Gastroenterol; 2003 Nov; 98(11):2409-14. PubMed ID: 14638341
[TBL] [Abstract][Full Text] [Related]
17. [The effect of Helicobacter pylori eradication on chronic use of acid-suppressant medication by patients in general practice; a randomised, double-blind study].
Hurenkamp GJ; Grundmeijer HG; van der Ende A; Tytgat GN; Assendelft WJ; van der Hulst RW
Ned Tijdschr Geneeskd; 2004 Nov; 148(48):2390-6. PubMed ID: 15615275
[TBL] [Abstract][Full Text] [Related]
18. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of Helicobacter pylori "test and treat" for patients with typical reflux symptoms in a population with a high prevalence of H. pylori infection: a Markov model analysis.
You JH; Wong PL; Wu JC
Scand J Gastroenterol; 2006 Jan; 41(1):21-9. PubMed ID: 16373272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
